Global qPCR and dPCR Market 2015-2019

01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Overview
07. Market Landscape
07.1 Market Overview
07.2 Market Size and Forecast
07.3 qPCR and dPCR Market in US
07.3.1 Market Size and Forecast
07.4 qPCR and dPCR Market in Europe
07.4.1 Market Size and Forecast
07.5 qPCR and dPCR Market in Japan
07.5.1 Market Size and Forecast
07.6 Five Forces Analysis
08. Market Segmentation by Application
09. Market Segmentation by Technology
09.1 Global qPCR Market
09.1.1 Market Size and Forecast
09.2 Global dPCR Market
09.2.1 Market Size and Forecast
10. Market Segmentation by Product Type
10.1 Global qPCR and dPCR Consumables Market
10.1.1 Market Size and Forecast
10.2 Global qPCR and dPCR Instruments Market
10.2.1 Market Size and Forecast
10.3 Global qPCR and dPCR Services Market
10.3.1 Market Size and Forecast
11. Geographical Segmentation
11.1 qPCR and dPCR Market in Americas
11.1.1 Market Size and Forecast
11.2 qPCR and dPCR Market in EMEA Region
11.2.1 Market Size and Forecast
11.3 qPCR and dPCR Market in APAC Region
11.3.1 Market Size and Forecast
12. Buying Criteria
13. Market Growth Drivers
14. Drivers and their Impact
15. Market Challenges
16. Impact of Drivers and Challenges
17. Market Trends
18. Trends and their Impact
19. Vendor Landscape
19.1 Competitive Scenario
19.1.1 Key News
19.1.2 Mergers and Acquisitions
19.2 Vendor Analysis 2014
19.3 Other Prominent Vendors
20. Key Vendor Analysis
20.1 Abbott Laboratories
20.1.1 Key Facts
20.1.2 Business Overview
20.1.3 Business Segmentation by Revenue
20.1.4 Business Segmentation by Revenue 2011 and 2012
20.1.5 Geographical Segmentation by Revenue
20.1.6 Business Strategy
20.1.7 Key Information
20.1.8 SWOT Analysis
20.2 Agilent Technologies
20.2.1 Key Facts
20.2.2 Business Overview
20.2.3 Business Segmentation by Revenue 2013
20.2.4 Business Segmentation by Revenue 2012 and 2013
20.2.5 Geographical Segmentation by Revenue 2013
20.2.6 Business Strategy
20.2.7 Recent Developments
20.2.8 SWOT Analysis
20.3 Bio-Rad Laboratories
20.3.1 Key Facts
20.3.2 Business Overview
20.3.3 Business Segmentation
20.3.4 Business Strategy
20.3.5 Business Segmentation by Revenue
20.3.6 Business Segmentation by Revenue 2011 and 2012
20.3.7 Geographical Segmentation by Revenue 2012
20.3.8 Key Developments
20.3.9 SWOT Analysis
20.4 F. Hoffmann-La Roche
20.4.1 Key Facts
20.4.2 Business Overview
20.4.3 Business Segmentation
20.4.4 Geographical Segmentation by Revenue 2013
20.4.5 Business Strategy
20.4.6 Key Information
20.4.7 SWOT Analysis
20.5 Thermo Fisher Scientific
20.5.1 Key Facts
20.5.2 Business Overview
20.5.3 Business Segmentation
20.5.4 Product Segmentation by Revenue
20.5.5 Sales Segmentation
20.5.6 Business Strategy
20.5.7 Key Information
20.5.8 SWOT Analysis
20.6 Qiagen
20.6.1 Key Facts
20.6.2 Business Overview
20.6.3 Product Segmentation by Revenue 2013
20.6.4 Product Segmentation by Revenue 2012 and 2013
20.6.5 Geographical Segmentation by Revenue 2013
20.6.6 Business Strategy
20.6.7 Recent Developments
20.6.8 SWOT Analysis
21. Other Reports in this Series